Free Trial

ConvaTec Group (LON:CTEC) Receives "Buy" Rating from Deutsche Bank Aktiengesellschaft

ConvaTec Group logo with Medical background

ConvaTec Group (LON:CTEC - Get Free Report)'s stock had its "buy" rating reiterated by investment analysts at Deutsche Bank Aktiengesellschaft in a report released on Thursday, Marketbeat Ratings reports. They presently have a GBX 315 ($4.30) price objective on the stock. Deutsche Bank Aktiengesellschaft's target price would suggest a potential upside of 18.78% from the company's current price.

Separately, Berenberg Bank restated a "buy" rating and issued a GBX 310 ($4.23) price objective on shares of ConvaTec Group in a research note on Wednesday, March 5th.

Read Our Latest Stock Analysis on ConvaTec Group

ConvaTec Group Stock Performance

CTEC stock opened at GBX 265.20 ($3.62) on Thursday. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The firm has a market cap of £6.74 billion, a PE ratio of 44.66, a P/E/G ratio of 0.93 and a beta of 0.64. The business has a 50 day moving average of GBX 277.51 and a 200-day moving average of GBX 255.28. ConvaTec Group has a 12-month low of GBX 211.80 ($2.89) and a 12-month high of GBX 311.20 ($4.25).

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ConvaTec Group Right Now?

Before you consider ConvaTec Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.

While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines